LENZ Therapeutics Eye Drug Profile Supports Blockbuster Opportunity: Analyst - LENZ Therapeutics (NASDAQ:

LENZ Therapeutics partners with Arrotex to commercialize VIZZ in Australia and New Zealand as analysts remain focused on U.S. growth.

Raccontata dabenzinga.com